20285 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF
#2BIOFILM DISRUPTION
#3METAP2 INHIBITORS AND METHODS OF TREATING OBESITY
#4COMPOSITIONS AND METHODS FOR REDUCING CANCER STEM CELLS
#5STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#6COMBINATION OF RADIATION/CHEMOTHERAPY, PD-1 INHIBITOR AND FATTY ACID SYNTHASE INHIBITOR
#7FERROPTOSIS INHIBITOR
#8COMPOSITIONS AND METHODS FOR USE IN KRAS-TARGETED THERAPIES FOR THE TREATMENT OF CANCER
#9COMPOSITION COMPRISING DELTA-9-TETRAHYDROCANNABINOL AND TERPENES
#10POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
#11PSEUDO-DISACCHARIDE COMPOUNDS
#12METHOD FOR INDUCING TUMOR REGRESSION
#13ASSESSING AND TREATING CANCER
#14METHOD FOR ENHANCING IMMUNE SYSTEM FUNCTIONS IN A SUBJECT
#15Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors
#16METHOD FOR PREVENTING OR TREATING HEARING LOSS
#17COMBINATION THERAPIES
#18METAP2 INHIBITORS AND USES THEREOF
#19COMPOSITIONS AND METHODS RELATING TO PEDIATRIC NEUROMUSCULAR DISEASES AND NEUROGENERATIVE DISORDERS
#20PLANT-DERIVED NEUROPROTECTIVE COMPOSITION AND A METHOD OF MANUFACTURING THE SAME
#21METHODS OF TREATING BRAIN TUMOURS AND NEUROBLASTOMAS
#22COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IMPAIRED ß-GALACTOSIDASE ACTIVITY
#23INHALABLE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR TREATMENT OF FIBROTIC AUTOIMMUNE OR INFLAMMATORY LUNG DISEASES
#24New VASHs inhibitors, conjugates thereof and their uses as drugs or as research tools
#25COMPOSITIONS AND METHODS FOR MODULATING HYDROXYLATION OF ACC2 BY PHD3
#26Substituted alkylphenols as HCN1 antagonists
#27A WATER SOLUBLE OR WATER DISPERSIBLE BOLUS ARTICLE
#28DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)
#29PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
#30METHOD FOR ENHANCING IMMUNE SYSTEM FUNCTIONS IN A SUBJECT
#31USE OF FATTY ACID OXIDATION INHIBITORS AS ANTIMICROBIALS
#32COMPOUNDS FOR TREATING HEPATOCELLULAR CARCINOMA
#33COMBINATIONS OF METAP2 INHIBITORS AND CD4/6 INHIBITORS FOR THE TREATMENT OF CANCER
#34COMPOSITIONS FOR ALTERING A MICROGLIAL CELL, AND METHODS OF USE THEREFORE
#35DIANHYDROGALACTITOL FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS
#36METHOD FOR ACTIVATING FOLLICLES BY MEANS OF USING SMALL-MOLECULE COMPOUND, AND PREPARATION THEREOF
#37Tiglien-3-one derivatives
#38OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES
#39Method for inducing tumor regression
#40COMPOSITION CONTAINING CAROTENOIDS AND USE THEREOF FOR PROTECTING NEURONS AGAINST NEURODEGENERATION
#41DETERMINATION OF NFKB PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES
#42COMPOSITIONS COMPRISING FUCOXANTHIN AND USE THEREOF IN REDUCTION OF FAT ACCUMULATION IN CELLS
#43COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY
#44CYSTEINE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR TREATMENT OF CORONAVIRUS
#45NEW STRATEGY FOR TREATING PANCREATIC CANCER
#46USES OF A CAROTENOID IN THE TREATMENT OR PREVENTION OF STRESS INDUCED CONDITIONS
#47COMPOSITIONS COMPRISING NOVEL CANNABINOID AND TERPENE PROFILES
#48POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
#49COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES
#50HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS
#51METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM CELLS
#52METAP2 INHIBITORS AND METHODS OF TREATING OBESITY
#53SOLID STATE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR PRODUCING AND USING SAME
#54COMBINED USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] AND ETOMOXIR FOR TREATING CANCERS
#55USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES
#56THERAPEUTIC APPROACH FOR TREATING INFLAMMATORY BOWEL DISEASE
#57UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#58Synergistic Combinations of Amino Acid Depletion Agent Sensitizers (AADAS) and Amino Acid Depletion Agents (AADA), and Therapeutic Methods of Use Thereof
#59Method for inhibiting Zika virus infection
#60Method for inhibiting dengue virus infection
#61Method for inhibiting Zika virus infection
#62Method for inhibiting dengue virus infection
#63BIOFILM DISRUPTION
#64METHOD FOR INDUCING TUMOR REGRESSION
#65TREATMENT FOR TUMORS DRIVEN BY METABOLIC DYSFUCTION
#66FATTY ACID DERIVATIVES AND THEIR USE
#67COMPOSITIONS AND METHODS FOR MODULATING VIRAL INFECTIONS BY REGULATING GLUCOSYLCERAMIDES
#68METHODS OF ALTERING CARDIAC REMODELING USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION
#69COMBINATION THERAPIES THAT INCLUDE AN AGENT THAT PROMOTES GLUCOSE OXIDATION AND AN INHIBITOR OF PYRUVATE DEHYDROGENASE KINASE
#70Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas
#71METHODS OF TREATING MENTAL DISORDERS
#72USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA
#73Method of treating tumours
#74USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES
#75Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases
#76USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA
#77COMPOSITIONS COMPRISING CAROTENOIDS AND USE THEREOF
#78PHARMACEUTICAL DOSAGE FORM OF COLESTIPOL
#79Optimizing volatile entourages in dry flowering plant mixtures
#80Optimizing volatile entourages in dry flowering plant mixtures
#81Pharmaceutical compositions of dimethyl fumarate
#82METHOD FOR MITIGATION OF NON-ALCOHOLIC FATTY LIVER DISEASE BY USE OF A COMPOSITION COMPRISING SMALL-MOLECULE FUCOIDAN AND FUCOXANTHIN
#83Composition comprising high purity pyrrole derivative and method for preparation thereof
#84AGENTS THAT INHIBIT NGLY1 AND METHODS OF USE THEREOF
#85COMBINATION OF PRMT5 INHIBITORS AND BCL-2 INHIBITORS
#86Stabilized microcapsules, method of their preparation and uses thereof
#87Stabilized microcapsules, method of their preparation and uses thereof
#88STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#89P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same
#90Composition for the treatment of COVID-19 infection, and a method of treatment
#91COMPOSITIONS AND METHODS FOR REDUCING CANCER STEM CELLS
#92AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same
#93METHODS FOR TREATING A CANCER RESISTANT TO AT LEAST ONE TYROSINE KINASE INHIBITOR
#94Hepatitis B antiviral agents
#95Nucleic acid modifiers
#96SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF
#97TIGLIEN-3-ONE DERIVATIVES
#98COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
#99NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME
#100COMPOSITIONS COMPRISING FUCOXANTHIN AND USE THEREOF IN PREVENTION AND TREATMENT OF FATTY LIVER DISEASE
#101POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
#102Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide
#103COMPOSITIONS AND METHODS FOR MODULATING HYDROXYLATION OF ACC2 BY PHD3
#104METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASE OR DISORDER
#105Interactional Biosystem
#106DENTAL CARE CANNABIS DEVICE AND USE THEREOF
#107Method for inducing tumor regression
#108Inhibitors of glucosylceramide degradation in the treatment of diseases of the motor units
#109Treatment for tumors driven by metabolic dysfunction
#110Prodrug compositions, prodrug nanoparticles, and methods of use thereof
#111Optimizing volatile entourages in dry flowering plant mixtures
#112Use of fatty acid oxidation inhibitors as antimicrobials
#113Composition for the treatment of dysbiosis of the intestinal microbiota
#114Targeting Lipid Metabolism and Free Fatty Acid (FFA) Oxidation to Treat Diseases Mediated by Resident Memory T Cells (TRM)
#115Compositions and methods to protect mammalian tissue against cold and other metabolic stresses
#116METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 AND FATTY ACID METABOLISM INHIBITORS
#117Anti-flavivirus compounds and methods of use
#118COMBINATION THERAPY FOR IMMUNOLOGICAL DISEASES
#119Food supplement
#120PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER, CONTAINING MALATE-ASPARTATE SHUTTLE INHIBITOR AND ANTICANCER DRUG AS ACTIVE INGREDIENTS
#121COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES
#122ISOLATION OF PLANT EXTRACTS
#123Process for producing fucoxanthin and/or polysaccharides from microalgae
#124Hepatitis B antiviral agents
#125Anti-flavivirus compounds and methods of use
#126Tiglien-3-one derivatives
#127MetAP2 inhibitors and methods of treating obesity
#128Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy
#129Pharmaceutical compositions of dimethyl fumarate
#130METHODS OF CANCER TREATMENT
#131COMPOSITIONS AND METHODS FOR TREATMENT OF MICROSPORIDIA INFECTION USING PROTEASOME INHIBITORS INCLUDING IXAZOMIB
#132COMPOUNDS AND COMPOSITIONS FOR EXTENDING LIFESPAN OF A SUBJECT
#133Altertoxin II as a selective inhibitor of Ewing family of tumor cells
#134ARIANTS OF 2-[6-(4-CHLOROPHENOXY)HEXYL]-OXIRANE-2-CARBOXYLIC ACID FOR USE IN THE TREATMENT, PREVENTION AND/OR AMELIORATION OF BRAIN DISEASES
#135USE OF DIANHYDROGALACTITOL OR ANALOGS AND DERIVATIVES IN COMBINATION WITH VEGF INHIBITORS TO TREAT CANCER
#136USE OF DIANHYDROGALACTITOL OR ANALOGS AND DERIVATIVES IN COMBINATION WITH A P53 MODULATOR OR A PARP INHIBITOR
#137Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
#138CRYOPRESERVED PLATELET COMPOSITIONS AND METHODS FOR MAKING
#139Combination therapy for the treatment or prevention of tumours
#140PHARMACEUTICAL COMPOSITIONS OF METAP-2 INHIBITORS
#141Oil-free carotenoid composition
#142FUMAGILLOL TYPE COMPOUNDS AND METHODS OF MAKING AND USING SAME
#143Non-aromatic difluoro analogues of resorcylic acid lactones
#144Methods of improving cell-based therapy
#145Agents that inhibit NGLY1 and methods of use thereof
#146Nitric oxide donors
#147Compositions for the treatment of skin conditions
#148DIABETES POLYGENIC RISK SCORE
#149Methods of cancer treatment
#150Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases
#151Methods of Treating an Overweight or Obese Subject
#152Compositions and methods for modulating metabolic pathways
#153Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases
#154Prodrug compositions, prodrug nanoparticles, and methods of use thereof
#155BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF
#156Pharmaceutical composition for preventing or treating LDL cholesterol-related diseases, containing ribosome-binding preparation
#157USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES
#158COMPOSITIONS AND METHODS FOR CARDIAC REPAIR
#159METHODS OF TREATING AGE RELATED DISORDERS
#160Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies
#161Uses of a carotenoid in the treatment or prevention of stress induced conditions
#162Transmucosal Delivery of Terpenes Via Edible Film
#163Methods and compositions for wound healing
#164METHOD OF TREATMENT
#165Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereof
#166METHOD FOR MITIGATING METASTASIS
#167Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma
#168INHIBITORS OF GLUCOSYLCERAMIDE DEGRADATION IN THE TREATMENT OF DISEASES OF THE MOTOR UNITS
#169Methods of treating mental disorders
#170Production method of edible sustained-release functional material and edible sustained-release functional material
#171Tiglien-3-one derivatives
#172FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
#173Pharmaceutical compositions of dimethyl fumarate
#174USE OF DIANHYDROGALACTITOL AND DERIVATIVES THEREOF IN THE TREATMENT OF GLIOBLASTOMA, LUNG CANCER, AND OVARIAN CANCER
#175Hepatitis B antiviral agents
#176Targeting Casein Kinase-1 and PI3K/AKT/mTOR Pathways for Treatment of c-Myc-Overexpressing Cancers, Organ Transplant Associated Complications and Autoimmune Diseases
#177COMPOSITIONS OF CB2 RECEPTOR SELECTIVE AGONISTS FOR TREATMENT OF MENTAL DISORDERS
#1782,3-epoxy succinyl derivative, preparation method and use thereof
#179Compositions and methods for treating diabetic retinopathy
#180Pharmaceutical composition for prevention of diet induced obesity
#181SHIKIMATE ANALOGUES AND METHODS OF USE
#182FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
#183METHODS OF TREATING AN OVERWEIGHT OR OBESE SUBJECT
#184COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES
#185USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF, TOGETHER WITH RADIATION, TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND GLIOBLASTOMA MULTIFORME AND SUPPRESS PROLIFERATION OF CANCER STEM CELLS
#186Proteasome modulation for treatment of corneal disorders
#187Fumigillol compounds and methods of making and using same
#188Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase
#189HALOGENATED ESTERS OF CYCLOPROPANATED UNSATURATED FATTY ACIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
#190TREATMENT OF PROSTATE CANCER CELLS WITH FAT OXIDATION INHIBITORS AND ENZALUTAMIDE
#191TRIPLET-TRIPLET ANNIHILATION-BASED UPCONVERSION
#192Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
#193Pharmaceutical composition for preventing or treating autoimmune diseases comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof
#194Cosmetic composition for preventing or ameliorating hypersensitive skin comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof
#195Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
#196METAP2 inhibitors and methods of treating obesity
#197METHODS OF CANCER TREATMENT
#198BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE
#199Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol
#200METHODS FOR REDUCING PROTEOTOXICITY
#201Reducing the reproductive capacity of mammals
#202Ceramide derivatives as anticancer agents
#203Methods of improving cell-based therapy
#204Anti-dandruff compositions comprising a spirofuranone lactam tetramic acid derivative
#205Non-aromatic difluoro analogues of resorcylic acid lactones
#206COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL AND DIACETYLDIANHYDROGALACTITOL
#207USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF IN COMBINATION WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND BRAIN METASTASES
#208CYP450 lipid metabolites reduce inflammation and angiogenesis
#209Composition for preventing or treating disease caused by overproduction of dihydrotestosterone comprising fucoxanthin
#210Hypoestoxide, derivatives, related compounds, and agonists thereof for treatment or prevention of neurodegenerative diseases
#211IDENTIFICATION AND USE OF VERY LONG CHAIN DICARBOXYLIC ACIDS FOR DISEASE DIAGNOSIS, CHEMOPREVENTION, AND TREATMENT
#212Methods of treating ischemic organ damage and other disorders
#213Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using same
#214COMPOSITIONS COMPRISING CAROTENOIDS AND USE THEREOF
#215USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES
#216Methods of Treating an Overweight or Obese Subject
#217Methods of treating an overweight subject
#218Fumagillol derivatives
#219METHODS OF TREATING AGE RELATED DISORDERS
#220Methods of Treating an Overweight or Obese Subject
#221Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#222β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof
#223FAS inhibitors and methods associated therewith
#224Fumigillol compounds and methods of making and using same
#225Method of Reducing Uric Acid with Fucoxanthin-Containing Composition
#226Methods of treating impaired wound healing
#227Green synthesis of reduced graphene oxide using seed extract
#228Green synthesis of reduced graphene oxide using seed extract
#229Green synthesis of reduced graphene oxide using seed extract
#230METAP2 inhibitors and methods of treating obesity
#231Green synthesis of reduced graphene oxide silica nanocomposite using seeds extract
#232Compositions and methods for modulating metabolic pathways
#233HIV-CURE
#234LYOPHILIZED COMPOSITIONS CONTAINING A METAP-2 INHIBITOR
#235USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTFORME AND MEDULLOBLASTOMA
#236Hepatitis B antiviral agents
#237Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
#238Treatment for tumors driven by metabolic dysfunction
#239METHODS OF TREATING AGE RELATED DISORDERS
#240Compounds and methods for inhibiting production of trimethylamine
#241Methods and compositions for wound healing
#242TIGLIEN-3-ONE DERIVATIVES
#243Method of making nanocomposites of metal oxide and reduced graphene oxide and use for cancer treatment
#244Trail enhancers for the selective killing of cancer cells
#245Crystalline solids of a metAP-2 inhibitor and methods of making and using same
#246BH4 antagonists and methods related thereto
#247Methods of treating an overweight or obese subject
#248Suspension of graphene oxide nanoflakes in water, its use and a method of preparation thereof
#249MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#250Determination of NFkB pathway activity using unique combination of target genes
#251Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
#252MetAP2 inhibitors and methods of treating obesity
#253MetAP-2 inhibitor polymersomes for therapeutic administration
#254MetAP-2 inhibitor polymersomes for therapeutic administration
#255Treatment of viral infections by modulation of host cell metabolic pathways
#256METAP2 inhibitors and methods of treating obesity
#257Compositions and methods for modulating metabolic pathways
#258Itch suppression by fucoxanthin
#259Anti-cancer agents and preparation thereof
#260Dihydroorotic and acid dehydrogenase inhibitor
#261Prodrug compositions, prodrug nanoparticles, and methods of use thereof
#262Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#263Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases
#264Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol
#265Compositions capable of enhancing thermogenesis and uses thereof
#266Compounds and methods for inhibiting Cif virulence factor
#267Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#268CARNITINE PALMITOYLTRANSFERASE 1 INHIBITORS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS
#269METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISORDERS
#270Tiglien-3-one derivatives
#271Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor
#272METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION
#273FUMAGILLOL TYPE COMPOUNDS AND METHODS OF MAKING AND USING SAME
#274Methods and compositions for wound healing
#275Compositions and methods for treating beta-amyloid related diseases
#276Methods of treating renal disease and other disorders
#277Commands and method of treating cancer via RHO pathway
#278METHODS OF IMPROVING CELL-BASED THERAPY
#279USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF IN COMBINATION WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND BRAIN METASTASES
#280Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
#281METAP2 inhibitors and methods of treating obesity
#282Methods of treating an overweight or obese subject
#283Methods of treating an overweight subject
#284CYP450 lipid metabolites reduce inflammation and angiogenesis
#285Process for producing fucoxanthinol extract and methods of use
#286Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
#287Methods for enhancing hematopoietic stem/progenitor cell engraftment
#288Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
#289Reducing the reproductive capacity of mammals
#290METHODS OF TREATING AN OVERWEIGHT OR OBESE SUBJECT
#291TREATMENT OF OBESITY USING NON-DAILY ADMINISTRATION OF 6-O-(4-DIMETHYLAMINOETHOXY) CINNAMOYL FUMAGILLOL
#292METHODS OF TREATING AN OVERWEIGHT OR OBESE SUBJECT
#293METHODS FOR TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS EMPLOYING DIANHYDROGALACTITOL, DIACETYLDIANHYDROGALACTITOL, DIBROMODULCITOL, OR ANALOGS OR DERIVATIVES THEREOF
#294METHODS OF TREATING A SUBJECT WITH BENIGN PROSTATE HYPERPLASIA
#295Methods of treating an overweight or obese subject
#296Methods of treating hypothalamic obesity
#297A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
#298OPTIMIZED DRUG CONJUGATES
#299ESSENTIAL OIL COMPOSITION FROM LEMON PEEL AS GROWTH PROMOTOR IN POULTRY INDUSTRY
#300Fumigillol type compounds and methods of making and using same